Prelude Therapeutics Inc (PRLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -127,173 | -121,832 | -115,438 | -111,694 | -56,929 |
| Depreciation Amortization | -2,867 | -2,304 | 3,915 | 2,279 | 542 |
| Accounts payable and accrued liabilities | 3,305 | -2,270 | -347 | 3,903 | 1,157 |
| Other Working Capital | 4,216 | -10,479 | 932 | 3,625 | 4,616 |
| Other Operating Activity | 19,631 | 29,822 | 27,209 | 18,356 | 4,437 |
| Operating Cash Flow | $-102,888 | $-107,063 | $-83,729 | $-83,531 | $-46,177 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 90,955 | -31,133 | 84,710 | -261,480 | N/A |
| PPE Investments | -764 | -3,513 | -3,019 | -2,323 | -621 |
| Investing Cash Flow | $90,191 | $-34,646 | $81,691 | $-263,803 | $-621 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -395 | N/A | N/A | N/A | -258 |
| Common Stock Issued | 439 | 136,412 | 815 | 165,200 | 166,730 |
| Other Financing Activity | -164 | -17 | 0 | -303 | 79,756 |
| Financing Cash Flow | $-120 | $136,395 | $815 | $164,897 | $246,228 |
| Beginning Cash Position | 29,335 | 34,649 | 35,872 | 218,309 | 18,879 |
| End Cash Position | 16,518 | 29,335 | 34,649 | 35,872 | 218,309 |
| Net Cash Flow | $-12,817 | $-5,314 | $-1,223 | $-182,437 | $199,430 |
| Free Cash Flow | |||||
| Operating Cash Flow | -102,888 | -107,063 | -83,729 | -83,531 | -46,177 |
| Capital Expenditure | -764 | -3,513 | -3,019 | -2,323 | -621 |
| Free Cash Flow | -103,652 | -110,576 | -86,748 | -85,854 | -46,798 |